|
Recent
Questions
"I
have polycistic kidney disease, but am otherwise healthy. I will
soon need a kidney transplant. Fortunately, my wife is the same
blood type as me and, although not a perfect tissue match, I am
thankful that she will be able to donate a kidney to me. My question
relates to the anti-rejection medicines required after the transplant.
"I have recently read a couple of articles suggesting that
if a bone marrow transplant is done first, and then the same donor
provides a kidney, anti-rejection medication after the kidney
transplant may not be necessary. If true, why doesn't this combination
of
procedures happen more regularly?"
--
P.M.

Dr. Miller's
reply:
"Formal
bone marrow transplantion is a much higher risk procedure for
the recipient than a kidney transplant. It requires ablation --
temporary destruction -- of the recipient's immune system and
blood-forming cells. During this period and even afterwards, the
recipient is at risk if the donor marrow does not take and recover.
And even if it does, the recipient is at risk of graft versus
host disease. Moreover, it is only likely to be successful if
extremely good matches exist between donor and recipient.
"All
this is said with current therapy. A great deal of research is
taking place in this area, and this assessment may not hold true
at some time in the future."
Transplant Week
will be the sole judge of the appropriateness of questions. Acceptance
of a question for posting does not imply any warranty or responsibility
for the accuracy of material contained therein. To submit a question,
please send it via email to editor@transplantweek.org.
As with all information
provided in this site, these questions-and-answers are offered
for educational purposes only, and are not intended nor implied
to be a substitute for professional medical advice. Always consult
your own physician or healthcare provider with any questions you
may have regarding a medical condition.
|